bpc 157 risk Are there concerns with the peptide BPC-157? Here's a summary of 36 research studies examining its effects on healing. Comment "podcast" and I'll send you a link to the full episode: The bpc-157 risks and side effects

AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes

Cyanocobalamin Aids in energy production by converting carbs into glucose

When working as a nurse, in hospital setting, all expiry dates would be taken seriously but the, one is dealing with another who is not making the decision etc hence a different situation entirely

Reasons for CAB+LEN: NNRTI mutations, integrase mutations, high viral loads, continued viremia on CAB/RPV alone 24% were cis/trans female, 42% Black/Af Am, 36% Latinx 94% achieved viral suppression at 8 weeks (47% suppressed at baseline) 71% were on q8wk CAB dosing, though the authors state initially using q4wk dosing may be prudent pending further study for patients with adherence challenges